Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MCE.DE Stock Summary
In the News
MCE.DE Financial details
Company Rating
Sell
Market Cap
232.64M
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
900
Optionable
No
Shortable
Yes
Earnings
20 May 2021
P/E
-34.3
Forward P/E
-
PEG
-
P/S
5.53
P/B
2.46
P/C
-
P/FCF
63.34
Quick Ratio
16.62
Current Ratio
19.02
Debt / Equity
0.78
LT Debt / Equity
0.66
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
115.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
74.03%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-10%
ROC
-0.01%
Gross Margin
100%
Oper. Margin
-5%
Profit Margin
-16%
Payout
-
Shs Outstand
16.5M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
9.0-15.9
52W High
-
52W Low
-
RSI
-
Rel Volume
2.56
Avg Volume
1.73K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.279333
-
-
Volatility
0.19%, 0.19%
Prev Close
-
Price
-
Change
-
MCE.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.94 | 0.03 | 0.27 | 2.57 | 2.62 | |
Net income per share | 2.67 | -3.25 | -0.56 | -0.19 | -0.41 | |
Operating cash flow per share | 0 | 0 | 0 | 0.26 | 0.35 | |
Free cash flow per share | 0 | 0 | 0 | 0.1 | 0.23 | |
Cash per share | 4.17 | 0.12 | 0.15 | 0.99 | 1.64 | |
Book value per share | 4.11 | 2.75 | 2.49 | 3.75 | 5.74 | |
Tangible book value per share | 4.11 | 2.74 | 2.48 | -0.83 | 1.44 | |
Share holders equity per share | 4.11 | 2.75 | 2.49 | 3.75 | 5.74 | |
Interest debt per share | -6.43 | 0 | 6.45 | 4.98 | 4.15 | |
Market cap | 16.35M | 15.95M | 16.84M | 152.92M | 223.33M | |
Enterprise value | 5.77M | 15.59M | 41.22M | 195.19M | 261.12M | |
P/E ratio | 2.18 | -1.65 | -7.41 | -70.46 | -33.82 | |
Price to sales ratio | 6.2 | 164.48 | 15.62 | 5.34 | 5.31 | |
POCF ratio | 0 | 0 | 0 | 53.2 | 39.23 | |
PFCF ratio | 0 | 0 | 0 | 132.8 | 60.8 | |
P/B Ratio | 1.42 | 1.95 | 1.68 | 3.66 | 2.42 | |
PTB ratio | 1.42 | 1.95 | 1.68 | 3.66 | 2.42 | |
EV to sales | 2.19 | 160.72 | 38.25 | 6.81 | 6.21 | |
Enterprise value over EBITDA | -0.64 | -49.78 | 30.74 | 48.48 | 44.06 | |
EV to operating cash flow | 0 | 0 | 0 | 67.91 | 45.87 | |
EV to free cash flow | 0 | 0 | 0 | 169.51 | 71.1 | |
Earnings yield | 0.46 | -0.61 | -0.13 | -0.01 | -0.03 | |
Free cash flow yield | 0 | 0 | 0 | 0.01 | 0.02 | |
Debt to equity | 0 | 0 | 2.5 | 1.28 | 0.7 | |
Debt to assets | 0 | 0 | 0.71 | 0.52 | 0.38 | |
Net debt to EBITDA | 1.17 | 1.16 | 18.19 | 10.5 | 6.38 | |
Current ratio | 192.44 | 156.66 | 22.59 | 14.93 | 19.02 | |
Interest coverage | 0.52 | -29.91 | 1.43 | -0.51 | -0.78 | |
Income quality | 0 | 0 | 0 | -1.32 | -0.86 | |
Dividend Yield | 0 | 0 | 0 | 0.11 | 0 | |
Payout ratio | 0 | 0 | 0 | -7.54 | 0 | |
Sales general and administrative to revenue | 0.11 | 1.57 | 0.39 | 0.04 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.49 | 0.41 | |
Capex to operating cash flow | 0 | 0 | 0 | -0.6 | -0.35 | |
Capex to revenue | 0 | 0 | 0 | -0.06 | -0.05 | |
Capex to depreciation | 0 | 0 | 0 | -0.33 | -0.25 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 15.71 | 14.17 | 5.62 | 4.05 | 7.28 | |
ROIC | -0.7 | -0.07 | 0.04 | -0.02 | -0.02 | |
Return on tangible assets | 0.56 | -0.84 | -0.06 | -0.04 | -0.07 | |
Graham Net | 3.55 | -0.99 | -6.16 | -4.34 | -2.9 | |
Working capital | 13.18M | 9M | 5.79M | 15.36M | 32.92M | |
Tangible asset value | 11.55M | 8.16M | 9.98M | -9.28M | 23.15M | |
Net current asset value | 11.5M | 5.73M | -19.32M | -45.26M | -42.36M | |
Invested capital | 0 | 0 | 2.5 | 1.28 | 0.7 | |
Average receivables | 769.36K | 0 | 0 | 1.03M | 3.07M | |
Average payables | 75.55K | 52.84K | 26.15K | 553.51K | 1.46M | |
Average inventory | 2.33K | 0 | 0 | 590.65K | 1.78M | |
Days sales outstanding | 0 | 0 | 0 | 26.23 | 35.49 | |
Days payables outstanding | 13.84 | 33.36 | 2.44 | 570.27 | -5.64K | |
Days of inventory on hand | 0 | 0 | 0 | 611.03 | -7.35K | |
Receivables turnover | 0 | 0 | 0 | 13.92 | 10.29 | |
Payables turnover | 26.37 | 10.94 | 149.43 | 0.64 | -0.06 | |
Inventory turnover | 0 | 0 | 0 | 0.6 | -0.05 | |
ROE | 0.65 | -1.18 | -0.23 | -0.05 | -0.07 | |
Capex per share | 0 | 0 | 0 | -0.15 | -0.13 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 20.28M | 42.27M | 28.94M | 37.79M | 39.68M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.68 | 1.28 | 0.66 | 0.7 | 0.78 | |
Debt to assets | 0.4 | 0.52 | 0.37 | 0.38 | 0.39 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 253.66 | 14.93 | 1.41 | 19.02 | 3 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.49 | 0.4 | 0.41 | 0.49 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 17.13M | 15.36M | 11.38M | 32.92M | 30.57M | |
Tangible asset value | 36.66M | -9.28M | 24.03M | 23.15M | 2.27M | |
Net current asset value | -8.29M | -45.26M | -27.97M | -42.36M | -48.08M | |
Invested capital | 0.68 | 1.28 | 0.66 | 0.7 | 0.78 | |
Average receivables | 0 | 1.03M | 5.59M | 6.61M | 4.51M | |
Average payables | 36.16K | 585.15K | 844.06K | 1.21M | 1.75M | |
Average inventory | 0 | 590.65K | 1.14M | 1.74M | 2.3M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
MCE.DE Frequently Asked Questions
What is MEDIQON Group AG stock symbol ?
MEDIQON Group AG is a DE stock and trading under the symbol MCE.DE
What is MEDIQON Group AG stock quote today ?
MEDIQON Group AG stock price is $- today.
Is MEDIQON Group AG stock public?
Yes, MEDIQON Group AG is a publicly traded company.